Xarelto Lawsuit Funding
Fair Rate Funding Now Offering Lawsuit Funding for Xarelto Lawsuits
Xarelto (rivaroxaban) is an anticoagulant (blood thinner) that prevents the formation of blood clots and is marketed by Johnson & Johnson and manufactured by Bayer. Its primary use is to reduce the risk of blood clots in the legs and lungs of people who recently had a hip or knee replacement surgery. It is also used to treat and reduce the risk of deep vein thrombosis, pulmonary embolisms and strokes.
Uncontrollable bleeding is the most dangerous risk associated with blood thinners. Other serious injury risks include bleeding in the intestines, rectal bleeding, brain hemorrhage and death.
The Institute for Safe Medication Practices revealed that blood thinners – including Xarelto – were the most dangerous drugs with the highest number of serious side effects reported to the FDA. http://www.drugwatch.com/xarelto/lawsuit/. Many patients and their physicians are concerned that Xarelto will cause the same serious bleeding complications as Pradaxa.
The complications are serious. Reports of dangerous blood clots are already being reported to the FDA by people who are or have taken the drug Xarelto. Some injuries that are currently being reported are:
A large number of lawsuits are now being filed against the manufactures (Bayer and Janssen Pharmaceuticals) that the defendant manufacturers concealed important safety information from the public and did not thoroughly test the medication before it was place for consumption in the marketplace.
Ultimately, the Xarelto lawsuit cases may be consolidated into a multi-district-litigation (MDL). When large numbers of plaintiffs file against only a few defendants, consolidation of cases can help simplify the litigation process because judges who are familiar with the facts can adjudicate the cases more efficiently. Plaintiffs will still keep their attorneys, but the cases are handled as a group for logistical reasons.
Because these lawsuits often require expert testimony to prove damages, the discovery process can often drag on for years. While this is going on, plaintiffs often encounter severe emotional and financial stress. This condition can be improved with some extra money. A lawsuit cash advance from Fair Rate Funding can help.
If you have a lawsuit based on damages caused by Xarelto and need Xarelto lawsuit funding or lawsuit funding in connection with any defective drug lawsuit, and have a lawyer representing you on a contingent fee basis (he/she only gets paid when you win your lawsuit) you may eligible for Xarelto lawsuit funding from Fair Rate Funding. If you are in the need of immediate cash while waiting for compensation on your case, Fair Rate Funding can provide a Xarelto lawsuit cash advance funding to help pay for your expenses while your case is being litigated.
We know you have a choice of Xarelto lawsuit funding companies and are happy to assist you in your time of need. To obtain a lawsuit loan in the quickest and easiest manner, please fill out the submission form on this page. One of our agents will contact you immediately and start the process. You can then simply sit back and allow Fair Rate Funding to do its job. We regularly process and provide lawsuit cash advances within 24 hours of receiving the paperwork from your attorney.
We provide Xarelto lawsuit funding in the following states: Alabama, Alaska, Arizona, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia D.C.
*Call Fair Rate Funding for details on what types of pharmaceutical cases are eligible for Xarelto lawsuit cash advance funding.
Thank you for choosing Fair Rate Funding.